Labcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.
- Revenue
- +6.92%
- EPS
- +3.18%
- Free cash flow
- +44.7%
- Total debt
- +3.21%
Quarter to September 2026, against a year earlier
Follow LH
Alert me
Labcorp Holdings Inc. (LH) P/E ratio
As of 5 November 2026, Labcorp Holdings Inc. (LH) trades at a P/E ratio of 29.5×. Over the past ten years it has ranged from 7.4× (December 2018) to 49.5× (January 2024); the current reading is higher than 85% of that period. That is below the Diagnostics & Research industry median of 34.5× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 23.8× | (7.72%) |
| FY2024 | 25.8× | (47.87%) |
| FY2023 | 49.5× | 239.34% |
| FY2022 | 14.6× | 33.53% |
| FY2021 | 10.9× | 0.17% |
| FY2020 | 10.9× | (36.48%) |
| FY2019 | 17.2× | 38.49% |
| FY2018 | 12.4× | 10.75% |
| FY2017 | 11.2× | (28.45%) |
| FY2016 | 15.6× | (36.00%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 25.1× | 9.14% |
| Jun 2026 | 23.0× | (2.04%) |
| Mar 2026 | 23.5× | (1.33%) |
| Dec 2025 | 23.8× | (14.93%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| DGX Quest Diagnostics Incorporated compare | 25.0× |
| LH Labcorp Holdings Inc. | 29.5× |
| IQV IQVIA Holdings Inc. compare | 31.8× |
| A Agilent Technologies, Inc. compare | 33.8× |
| MEDP Medpace Holdings, Inc. compare | 34.6× |
| ILMN Illumina, Inc. compare | 35.6× |
| MTD Mettler-Toledo International, Inc. compare | 37.6× |
| WAT Waters Corporation compare | 194× |
| Diagnostics & Research industry median | 34.5× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on LH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement